GSK plans to increase stakes in both India and Nigeria

Pharmaceuticals giant GlaxoSmithKline has announced a voluntary open offer to increase its holding in its publicly-listed Consumer Healthcare subsidiary in India.

Pharmaceuticals giant GlaxoSmithKline has announced a voluntary open offer to increase its holding in its publicly-listed Consumer Healthcare subsidiary in India.

The company also said it has come to an agreement on the terms of a proposal to increase its ownership in GlaxoSmithKline Consumer Nigeria, which manufactures, markets and distributes a wide range of Consumer Healthcare brands, to 80%.

Increasing stake in Indian subsidiaryGSK has made an offer to increase its stake in GlaxoSmithKline Consumer Healthcare from 43.2% to up to 75% at a price of INR 3,900 per share. This percentage would allow securities relations in India to maintain the minimum public shareholidng of 25% that enables the company to retain a public listing in the country.

GSK wants to acquire up to 13.39m shares, equal to 31.8% of the total outstanding shares, at a premium of about 28% to the closing price on Friday November 23rd. The total value of the transaction is potentialy £591m.

David Redfern, Chief Strategy Officer, GSK said: "GSK Consumer Healthcare is a well established business in India and its leading product, Horlicks, is an iconic household brand. This transaction represents a further step in GSK's strategy to invest in the world's fastest growing markets and, we believe, offers a liquidity opportunity at an attractive premium for existing shareholders."

The transaction will be funded through GSK's existing cash resources, will be earnings neutral for the first year and accretive thereafter and will not impact expectations for the group's long-term share buyback programme, it said.

Building stake in GlaxoSmithKline Consumer NigeriaThe group has agreed in principle to increase its stake in GlaxoSmithKline Consumer Nigeria from 46.4% to 80%, with the other 20% remaining a public shareholding, in line with the minimum requirement for a company to maintain a listing on the Nigerian Stock Exchange.

GSK will purchase around 321m shares in the company from public shareholders at an offer price of NGN 48 per share.

Approximately 70% of the company's revenue is from Consumer Healthcare Brands and 30% is from Pharmaceuticals and Vaccines.

The offer represents a premium of 28% to the company's closing share price on November 23rd.

David Redfern, Chief Strategy Officer, GSK said: "This Proposal to increase GSK's ownership of GlaxoSmithKline Consumer Nigeria reiterates our long term support of the Company's strategy and our confidence in the continuing growth prospects of the business."

The transaction will be funded through GSK's existing cash resources, will be modestly earnings accretive immediately, and will not impact expectations for the group's long-term share buyback programme.

NR

Recommended

How to invest today? Look to the past, not the future
Investment strategy

How to invest today? Look to the past, not the future

The past few years have seen so many changes to our way of life that many people said we had entered a “new normal”. But as it turns out, the new norm…
18 Aug 2022
A new legal headache for Haleon
Stocks and shares

A new legal headache for Haleon

Haleon, GSK’s former consumer-products arm, spun off last month, has made a dismal debut on the stockmarket.
17 Aug 2022
Persimmon yields 12.7%, but can you trust it to deliver?
Share tips

Persimmon yields 12.7%, but can you trust it to deliver?

With a dividend yield of 12.7%, Persimmon looks like a highly attractive prospect for income investors. But that sort of yield can also indicate a com…
17 Aug 2022
Cineworld faces a bleak future – investors should stay away
Share tips

Cineworld faces a bleak future – investors should stay away

Weighed down by crippling debts and with consumers tightening their belts, Cineworld's future does not look bright, says Rupert Hargreaves. Investors …
17 Aug 2022

Most Popular

Investors should get ready for a political revolution
UK Economy

Investors should get ready for a political revolution

Liz Truss will beat Rishi Sunak, cut taxes, and then shake up the Bank of England, says Helen Thomas
15 Aug 2022
How to protect your wealth as inflation hits new record highs
Investment strategy

How to protect your wealth as inflation hits new record highs

UK inflation has hit a new record high of 10.1%. It's going to hurt, says Dominic Frisby. Here's how you can protect your wealth.
17 Aug 2022
Don’t listen to the doom-mongers – the future is bright
Economy

Don’t listen to the doom-mongers – the future is bright

With volatile markets, raging inflation and industrial unrest, it may feel like things are bad and likely to get worse. But the end of the world is no…
15 Aug 2022